Investors News Releases Sign up for email alerts to receive company and investor updates News Releases Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Annual Reports News Releases Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nov 13 2006 Cyclacel Pharmaceuticals reports third quarter 2006 financial results Nov 10 2006 Cyclacel reports Phase I sapacitabine study results at 18th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics meeting Nov 06 2006 Cyclacel Pharmaceuticals to announce third quarter 2006 financial results on November 13, 2006 Oct 30 2006 Cyclacel Pharmaceuticals to present at Rodman & Renshaw annual healthcare conference Oct 24 2006 Cyclacel Pharmaceuticals to present at C.E. Unterberg, Towbin Emerging Opportunities in Healthcare Conference Oct 24 2006 Cyclacel Pharmaceuticals names John Womelsdorf, Ph.D., Vice President, Business Development Oct 23 2006 Cyclacel Pharmaceuticals, Inc. announces quarterly dividend for 6% Convertible Exchangeable Preferred Stock Sep 05 2006 Cyclacel Pharmaceuticals to present at Thomson Financial and Biocentury's: NewsMakers in the Biotech Industry Conference Aug 14 2006 Cyclacel Pharmaceuticals Reports Second Quarter 2006 Financial Results Jul 19 2006 Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock Jun 29 2006 Cyclacel Begins A Phase IIb Randomized Trial Of Seliciclib For Previously Treated Non-Small Cell Lung Cancer Jun 15 2006 Cyclacel Begins Phase I Pharmacologic Study Of Oral Sapacitabine In Patients With Advanced Leukemias Jun 12 2006 Cyclacel Pharmaceuticals To Present At 5th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference 2006 May 18 2006 Cyclacel Pharmaceuticals To Present At Bioequity Europe 2006 May 18 2006 Cyclacel Boosts Clinical Work With $45M Private Placement May 04 2006 Cyclacel Pharmaceuticals To Present At Rodman And Renshaw 3rd Annual Global Healthcare Conference Apr 27 2006 Cyclacel Pharmaceuticals Announces $45 Million Private Placement Apr 19 2006 Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock Apr 06 2006 Cyclacel Pharmaceuticals To Present At BIO 2006 Annual International Convention Mar 28 2006 Cyclacel Pharmaceuticals Begins Trading On NASDAQ With CYCC Ticker Symbol Mar 28 2006 Cyclacel Pharmaceuticals Established With Completion Of Cyclacel Group Plc And Xcyte Therapies Transactions Mar 06 2006 Cyclacel presents at Cowen Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Current page 20 Toolkit Email AlertsRSS FeedsPrint Page
News Releases Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nov 13 2006 Cyclacel Pharmaceuticals reports third quarter 2006 financial results Nov 10 2006 Cyclacel reports Phase I sapacitabine study results at 18th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics meeting Nov 06 2006 Cyclacel Pharmaceuticals to announce third quarter 2006 financial results on November 13, 2006 Oct 30 2006 Cyclacel Pharmaceuticals to present at Rodman & Renshaw annual healthcare conference Oct 24 2006 Cyclacel Pharmaceuticals to present at C.E. Unterberg, Towbin Emerging Opportunities in Healthcare Conference Oct 24 2006 Cyclacel Pharmaceuticals names John Womelsdorf, Ph.D., Vice President, Business Development Oct 23 2006 Cyclacel Pharmaceuticals, Inc. announces quarterly dividend for 6% Convertible Exchangeable Preferred Stock Sep 05 2006 Cyclacel Pharmaceuticals to present at Thomson Financial and Biocentury's: NewsMakers in the Biotech Industry Conference Aug 14 2006 Cyclacel Pharmaceuticals Reports Second Quarter 2006 Financial Results Jul 19 2006 Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock Jun 29 2006 Cyclacel Begins A Phase IIb Randomized Trial Of Seliciclib For Previously Treated Non-Small Cell Lung Cancer Jun 15 2006 Cyclacel Begins Phase I Pharmacologic Study Of Oral Sapacitabine In Patients With Advanced Leukemias Jun 12 2006 Cyclacel Pharmaceuticals To Present At 5th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference 2006 May 18 2006 Cyclacel Pharmaceuticals To Present At Bioequity Europe 2006 May 18 2006 Cyclacel Boosts Clinical Work With $45M Private Placement May 04 2006 Cyclacel Pharmaceuticals To Present At Rodman And Renshaw 3rd Annual Global Healthcare Conference Apr 27 2006 Cyclacel Pharmaceuticals Announces $45 Million Private Placement Apr 19 2006 Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock Apr 06 2006 Cyclacel Pharmaceuticals To Present At BIO 2006 Annual International Convention Mar 28 2006 Cyclacel Pharmaceuticals Begins Trading On NASDAQ With CYCC Ticker Symbol Mar 28 2006 Cyclacel Pharmaceuticals Established With Completion Of Cyclacel Group Plc And Xcyte Therapies Transactions Mar 06 2006 Cyclacel presents at Cowen Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Current page 20
Nov 10 2006 Cyclacel reports Phase I sapacitabine study results at 18th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics meeting
Nov 06 2006 Cyclacel Pharmaceuticals to announce third quarter 2006 financial results on November 13, 2006
Oct 24 2006 Cyclacel Pharmaceuticals to present at C.E. Unterberg, Towbin Emerging Opportunities in Healthcare Conference
Oct 24 2006 Cyclacel Pharmaceuticals names John Womelsdorf, Ph.D., Vice President, Business Development
Oct 23 2006 Cyclacel Pharmaceuticals, Inc. announces quarterly dividend for 6% Convertible Exchangeable Preferred Stock
Sep 05 2006 Cyclacel Pharmaceuticals to present at Thomson Financial and Biocentury's: NewsMakers in the Biotech Industry Conference
Jul 19 2006 Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock
Jun 29 2006 Cyclacel Begins A Phase IIb Randomized Trial Of Seliciclib For Previously Treated Non-Small Cell Lung Cancer
Jun 15 2006 Cyclacel Begins Phase I Pharmacologic Study Of Oral Sapacitabine In Patients With Advanced Leukemias
Jun 12 2006 Cyclacel Pharmaceuticals To Present At 5th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference 2006
May 04 2006 Cyclacel Pharmaceuticals To Present At Rodman And Renshaw 3rd Annual Global Healthcare Conference
Apr 19 2006 Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock
Mar 28 2006 Cyclacel Pharmaceuticals Established With Completion Of Cyclacel Group Plc And Xcyte Therapies Transactions
